CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs taking different approaches to battling the COVID-19 virus.
Tags:
Source: CIRM
Credit:
